IL6 and colorectal carcinoma: Using metabolomic analysis of plasma from patients with CRC liver metastasis, Costantini et al. [23] identified that levels of 3-hydroxybutyrate, cholesterol, phospholipids, triglycerides, and IL-6 can accurately categorize individuals based on their disease-free survival (DFS).